CRISPR Ruling Invalidates Some Biotech Company Patents

The Broad Institute was the first to invent CRISPR-Cas9 technology for use in animal cells, the U.S. Patent and Trademark Office said, siding against two Nobel laureates in a long-running dispute that affects the licensing agreements of some hotly watched biotech companies. The Monday ruling determined Nobel winners Jennifer Doudna from the University of California … Read more